Burgeon Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 9

Burgeon Therapeutics General Information

Description

Developer of small-molecule innovative drugs designed to treat oncology and chronic diseases. The company utilizes a sustainable drug discovery and clinical translation platform to develop first-in-class therapies, providing the healthcare sector with bgt-001, bgt-002, bgt-004, besanota, zm26, and x04 to improve patient outcomes in metabolic and inflammatory conditions.

Contact Information

Website
www.burgeon-cn.com
Formerly Known As
BoJiYuan (Chongqing) Pharmaceutical Technology, Burgeon (Chongqing) Pharmaceutical Technology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 03, 5th Floor, Number 2, Lane 61
  • Shengxia Road, China (China Pilot Free Trade Zone)
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Room 03, 5th Floor, Number 2, Lane 61
  • Shengxia Road, China (China Pilot Free Trade Zone)
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Burgeon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A1) 28-Oct-2026 Completed Generating Revenue
4. Early Stage VC (Series A) 09-Feb-2024 Completed Generating Revenue
3. Early Stage VC 22-Sep-2022 Completed Pre-Clinical Trials
2. Early Stage VC 11-Jul-2022 Completed Pre-Clinical Trials
1. Early Stage VC 31-May-2021 Completed Pre-Clinical Trials
To view Burgeon Therapeutics’s complete valuation and funding history, request access »

Burgeon Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fuho Capital Venture Capital Minority
Triwise Capital Venture Capital Minority
Ningbo Zhichen Investment Management Growth/Expansion Minority
ChemExpress Corporation Minority
Genuine Investment Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Burgeon Therapeutics FAQs

  • When was Burgeon Therapeutics founded?

    Burgeon Therapeutics was founded in 2020.

  • Where is Burgeon Therapeutics headquartered?

    Burgeon Therapeutics is headquartered in Shanghai, China.

  • What industry is Burgeon Therapeutics in?

    Burgeon Therapeutics’s primary industry is Drug Discovery.

  • Is Burgeon Therapeutics a private or public company?

    Burgeon Therapeutics is a Private company.

  • What is Burgeon Therapeutics’s current revenue?

    The current revenue for Burgeon Therapeutics is .

  • Who are Burgeon Therapeutics’s investors?

    Fuho Capital, Triwise Capital, Ningbo Zhichen Investment Management, ChemExpress, and Genuine Investment are 5 of 9 investors who have invested in Burgeon Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process